The Role of KLRG1 in Human CD4+ T-Cell Immunity Against Tuberculosis.

Zhidong Hu,Hui-Min Zhao,Chun-Ling Li,Xu-Hui Liu,Daniel Barkan,Douglas B. Lowrie,Shui-Hua Lu,Xiao-Yong Fan
DOI: https://doi.org/10.1093/infdis/jiy046
2018-01-01
Abstract:Background. KLRG1 is a marker of terminally differentiated CD8+ T cells in viral infection, but its role in human Mycobacterium tuberculosis infection remains elusive. Methods. A set of cohorts of patients with tuberculosis was designed, and the expression profiles and functions of KLRG1 CD4(+) T cells were determined with and without antibody blocking.R Results. KLRG1 expression on CD4(+) T cells was significantly increased in patients with active tuberculosis, compared with healthy controls and patients without tuberculosis. Upon M. tuberculosis-specific stimulation, the ability to secrete interferon y, interleukin 2, and tumor necrosis factor a was significantly greater in KLRG1-expressing CD4(+) T cells than in their KLRG-negative counterparts and was accompanied by a decreased proportion of regulatory T cells and increased Akt signaling. However, KLRG1expressing CD4(+) T cells had a shorter life-span, which was associated with a higher apoptosis rate but a similar proliferative response. Blockade of KLRG1 signaling significantly enhanced interferon y and interleukin 2 secretion without affecting either cell apoptosis or multiplication. Addition of a specific Akt inhibitor prevented this increased cytokine response, implicating the Akt signaling pathway. Conclusions. Our study delineated the profile of KLRG1 CD4(+) T cells in patients with tuberculosis and suggests that M. tuberculosis infection drives CD4(+) T cells to acquire increased effector function in a terminally differentiated state, which is restrained by KLRG1 via KLRG1/Akt signaling pathway.
What problem does this paper attempt to address?